Accentus Medical is a leading medical technology company that combines over 30 years of expertise in surface coating and modification technologies with dedicated research and development of new technologies for the medical device industry. Accentus Medical’s Acusure® range is designed to improve both biocompatibility and/or durability of orthopaedic and certain other implantable medical devices. The range includes a series of advanced hydroxyapatite and particulate metal coatings that are produced using proprietary inert/reducing gas, thermal plasma spraying techniques. Acusure® coatings have been in worldwide clinical usage for over 12 years. The company is also pioneering the development of an innovative surface modification treatment, called Agluna®, which binds silver ions into the surface of titanium and other metal alloy medical devices to produce a surface with proven anti-microbial properties. Agluna® is currently undergoing clinical evaluation by licensee Stanmore Implants Worldwide Ltd in the field of custom made tumour replacement prostheses, and its application as an anti-infective surface technology in many other medical devices is being evaluated, Joint Reconstruction, Trauma, Spine, Dentistry, Cardiology and Neurology for example. Accentus Medical is a private company that has its foundations in the United Kingdom Atomic Energy Authority, and is based at the pioneering Harwell Oxford campus, where the company has ISO 13485:2003 and ISO 9001:2008 accredited facilities.

DePuy Products, Inc., part of Johnson & Johnson, is a company headquartered in the United States. The firm manufactures and distributes orthopaedic devices.

Accentus LLC provides auditory display services. Its patented Auditory Display Solution presents market data with pleasant music. The company is headquartered in Lebanon, NH

Chongqing Runze Pharmaceutical Co., Ltd., established on 2007-12-24, Business scope includes production:Class III:6825Medical bipolar coagulator,6846-1implanted device,6846-2implantable artificial organ,6863-2Dental Implant Materials;Class II: 6810Surgical Power System,6825bipolar coagulation forceps,6863-7Metal,ceramic denture material(Engage in business according to the business scope and period approved by the respective licenses).medical instruments,Machine equipment and accessories,Chemical Products,specialty chemicals(None of the above contain hazardous chemicals),Biochemicals,Research and development of biological products and pharmaceuticals,Related technical consultation and transfer;Technical testing(Except for special regulations of the state);Sales:Class II:6810Orthopedic surgery(orthopedics)Surgical Instruments,6821Medical electronic equipment;Class II,Class III:(6846-1)Biological dural patch(6846-1)Cranial Fixation Titanium System6846Implantable materials and artificial organs(craniofacial fixation system,Cerebral Aneurysm Clips),6864Medical hygiene materials and dressings,6866Medical polymer materials and products,Chemical raw materials and their preparations,Antibiotic raw materials and their preparations,biochemical drug,Chinese patent medicine,Biological product(In addition to vaccines)(Engage in business according to the validity period and scope approved by the license);Production,Sales:environmental protection material.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Zimvie, Inc., Zimmer Dental, Inc. is an American company located in Carlsbad, CA, that manufactures dental implants.

Howmedica Osteonics Corp., a subsidiary of Stryker Corp., is a company headquartered in Mahwah, NJ. The firm manufactures and supplies orthopaedic devices.

DePuy Synthes Products, Inc. develops and markets medical products. It offers distal volar Radius, which is designed to treat distal radius fractures, dorsal endoplate, an invasive dorsal nail plate that provides fixed angle support and intramedullary locked fixation with a duplicate and reproducible surgical procedure, spatial subchondral support plate, which is used to treat proximal humeral fractures and Small Bone Fixation System, a percutaneous locked intramedullary nail system for metacarpals and the phalanges. The company was founded on June 22, 2004 and is headquartered in Wilmington, DE.

DePuy Ireland Unlimited Co., part of Johnson & Johnson, is a company headquartered in County Cork, Ireland. The firm develops and markets diagnostic and therapeutic products.

Synthesis BV engages in the design and production of synthetic water level regulation products. It offers penstocks, pipeline valves, accessories, channel slide gates, fish migration, float units, overflow pits, pivoted weirs, pipes, dirt grates, butterfly valve, and check valves. The company is headquartered in Emmeloord, the Netherlands.

Garwood Medical Devices LLC operates as a medical device company that provides measurable electrical stimulation treatments for chronic wound healing, bone growth and peri-prosthetic infection while freeing the patient from a power cord and the need for implanted batteries. The firm’s products include EnerAid wound care device and biofilm eradication system tethered. The company was founded by Gregg M. Gellman and is headquartered in Buffalo, NY.

PROTiP Medical SAS designs, develops, and markets medical prostheses and implants. The company manufactures complex form factors based on medical grade titanium microspheres. This means it can produce variants in final form, porosity, and even composition. The biomaterial thus obtained enables permanent implantation even in a septic environment. The company was founded by Maurice Berenger, G��rard Caillieret and Robert Devos in 2004 and is headquartered in Strasbourg, France.

Thommen Medical develops, produces and sells dental implants under the brand name SPI (Swiss Precision Implant) as well as biomaterial solutions for bone and tissue regeneration. Thommen Medical Implants are designed to be precise and easy to use, thanks to collaboration with leading scientific and dental clinicians.

ENBIO is the inventor , and trustee, of a remarkable technology called CoBlast., which offers industry the potential to redefine the performance, function and value of metals across all sectors. They are a young and vibrant company, operating as a trusted partner in some of industries most regulated and demanding markets, developing and delivering next-generation solutions to meet ever increasing material challenges. ENBIO offers clients the ability to quickly evaluate the potency of the CoBlast technology via its rapid sample production process, or through structured collaborative evaluation studies. Generally, the client identifies the chemistry of a required skin, whilst ENBIO focuses on and enables the practical delivery of such CoBlast chemistries.

Sulzer AG engages in the provision of pumping, agitation, mixing, separation, and purification technologies for fluids of all types. It operates through the following segments: Flow Equipment, Services, and Chemtech. The Flow Equipment segment offers pumping solutions specifically engineered for the processes of its customers. The Services segment provides parts as well as maintenance and repair solutions for pumps, turbines, compressors, motors, and generators. The Chemtech segment focuses on mass transfer, static mixing, and polymer solutions for chemicals, petrochemicals, refining, and LNG. The company was founded by Johann Jakob Sulzer-Neuffert in 1834 and is headquartered in Winterthur, Switzerland.

Beijing AK Medical Co., Ltd. offers orthopedic products and services. The firm provides surgical instruments and orthopedic products. Beijing AK Medical was founded in May 2003 and is headquartered in Beijing, China.

Dentsply IH AB, part of Dentsply Sirona, Inc., is a company headquartered in M��lndal, Sweden. The firm manufactures dental supplies.

Dentsply Implants Manufacturing GmbH, part of Dentsply Sirona, Inc., is a company headquartered in Mannheim, Germany. The firm manufactures and markets dental implants. It was founded in 1974. DENTSPLY International, Inc. acquired Dentsply Implants Manufacturing GmbH on March 13, 2001 for $100 million.